<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Comic Sans MS";
panose-1:3 15 7 2 3 3 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
h5
{mso-style-priority:9;
mso-style-link:"Heading 5 Char";
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:10.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.Heading5Char
{mso-style-name:"Heading 5 Char";
mso-style-priority:9;
mso-style-link:"Heading 5";
font-family:"Times New Roman","serif";
font-weight:bold;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Comic Sans MS";
color:navy;
font-weight:bold;
font-style:normal;
text-decoration:none none;}
span.EmailStyle22
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="color:#1F497D">Hello everyone,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">I sent emails on the inconsistent messaging and received a reply today from FDA. I attached the content, so you can see whether you want to copy something and send a similar message. FDA stated: “</span>We strive
to make our web pages as consistent as possible.<span style="color:#1F497D"> </span>
We will be considering the recent changes by DEA and revising our web pages as appropriate.”<o:p></o:p></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">I’ve seen a bit of change, so they are working on it, but I think they are missing the point: 1) Use collection programs or 2) sewer if there is a chance someone will be poisoned and 3) make clear it is guidance,
not required. I think we can live with that. I noticed they now refer to the DEA’s collection events. That’s new…and DEA is no longer doing those, so…I will write back to them to let them know that, because, clearly, they are not communicating with DEA, unless
DEA is going to still do events, but I believe we’ve heard a no on that. :/<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">I am thrilled some hospitals/clinics are becoming more concerned about environmental impacts and are switching to other disposal methods when it is clearly more expensive than sewering!<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">There are various links to disposal guidance from FDA, here’s the one that goes from ONDCP to FDA:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><a href="http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm101653.htm">http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm101653.htm</a>
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">I also ended up somewhere on a NIH website and tried to download prescription labels to see if sewering was “mandated” on those and it wouldn’t let me download them. Probably a good thing. Changing the labeling
and instructions that go home with the patient is another area that needs work. I am hopeful things will really change when pharmacies start collecting and making the changes needed to printed materials so customers use their bins.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">JV<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us]
<b>On Behalf Of </b>Lotzer Donna M<br>
<b>Sent:</b> Thursday, November 13, 2014 10:23 AM<br>
<b>To:</b> 'Hauser, Deborah'; 'pharmwaste@lists.dep.state.fl.us'<br>
<b>Subject:</b> RE: [Pharmwaste] inconsistent message<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Comic Sans MS";color:navy">Diazepam may be Schedule IV but if you look down this list they are the heavy hitters with a high high potential for abuse and are Schedule II in most cases. Do I
agree with flushing them? No…our hospital has recently gone to Cactus Sink instead of flushing or putting stuff in the sharps containers (!!) which is an improvement, albeit expensive. As a pharmacist with 25 years answering poison phones the more inaccessible
these products are the safer everyone is. Donna<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:maroon">Donna Lotzer, Senior Clinical Pharmacist
<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:maroon">Poison Education Coordinator</span></b><span style="color:navy"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:maroon">University of WI Hospital & Clinics Poison Prevention Center</span></b><span style="color:navy"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:maroon">600 Highland Avenue, MC # 9475, Madison, WI 53792</span></b><span style="color:navy"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:maroon"><a href="mailto:dlotzer@uwhealth.org">dlotzer@uwhealth.org</a> Phone: 608-265-8160</span></b><b><span style="color:navy"><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:#002060">Please encourage others to save 800-222-1222 in both cell and home phones.
<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:#002060">This number will connect callers anywhere in the U.S. to a poison center.
<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:#002060">Calls are free, confidential and answered 24/7/365.
<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:#002060">Please help me educate your community about poison prevention.
<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:7.5pt;font-family:"Tahoma","sans-serif";color:#002060">Call or email me for materials or program opportunities.<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:8.0pt;color:navy"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> Hauser, Deborah [mailto:Deborah.Hauser@epa.ohio.gov]
<br>
<b>Sent:</b> Thursday, November 13, 2014 6:56 AM<br>
<b>To:</b> pharmwaste@lists.dep.state.fl.us<br>
<b>Subject:</b> [Pharmwaste] inconsistent message<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Good morning,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">I’ve gotten the occasional question from hospital workers here in Ohio about policies to rinse Schedule IV drugs down the drain. As I generally work with the residential side of things, I’m not as well-versed on hospital practices. However,
it seems to me there is a serious disconnect between the message from the environmental folks (like my agency, Ohio EPA) and the FDA. The FDA’s most recent guidance still suggests flushing a lengthy list of pharms (see below). Has anyone had any experience
with hospitals making it a policy to NOT flush pharmaceuticals? As far as I know, it is still legal to flush the pharmaceuticals that FDA advises. But I guess I’d like to see some sort of solution that involves incinerating ALL pharms, even the ones that
have historically been flushed. Do any of you have any suggestions I could pass on to Ohio hospitals?<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Thanks,<o:p></o:p></p>
<p class="MsoNormal">Deb <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<table class="MsoNormalTable" border="0" cellspacing="3" cellpadding="0" summary="layout">
<thead>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal" align="center" style="text-align:center"><em><b><span style="font-family:"Calibri","sans-serif"">Medicine</span></b></em><b><span style="font-size:12.0pt"><o:p></o:p></span></b></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<h5 align="center" style="text-align:center"><em>Active Ingredient</em><o:p></o:p></h5>
</td>
</tr>
</thead>
<tbody>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM239930.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Abstral
</span></strong>(PDF - 1M)</a><strong><span style="font-family:"Calibri","sans-serif"">,
</span></strong>tablets (sublingual)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Fentanyl<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM085817.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Actiq
</span></strong>(PDF - 251KB)</a>, oral transmucosal lozenge <strong><span style="font-family:"Calibri","sans-serif"">*</span></strong><span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Fentanyl Citrate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Avinza
</span></strong>(PDF - 51KB)</a>, capsules (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Buprenorphine Hydrochloride</span></strong>, tablets (sublingual)
<strong><span style="font-family:"Calibri","sans-serif"">*</span></strong><span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Buprenorphine Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Buprenorphine Hydrochloride; Naloxone Hydrochloride</span></strong>, tablets (sublingual) *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Buprenorphine Hydrochloride; Naloxone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM219146.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Butrans</span></strong> (PDF - 388KB)</a>, transdermal patch system<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Buprenorphine<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM088581.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Daytrana</span></strong> (PDF - 281KB)</a>,<strong><span style="font-family:"Calibri","sans-serif"">
</span></strong>transdermal patch system<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Methylphenidate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Demerol</span></strong>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Meperidine Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Demerol</span></strong>, oral solution *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Meperidine Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif""><a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=DIASTAT" target="_blank">Diastat/Diastat AcuDial</a></span></strong>,
rectal gel [for disposal<br>
instructions: click on link, then go to "Label information"<br>
and view current label] <span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Diazepam<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Dilaudid</span></strong>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Hydromorphone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Dilaudid</span></strong>, oral liquid *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Hydromorphone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311370.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Dolophine Hydrochloride</span></strong> (PDF - 48KB)</a>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Methadone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM088584.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Duragesic</span></strong> (PDF - 179KB)</a>, patch (extended release)
<strong><span style="font-family:"Calibri","sans-serif"">*</span></strong><span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Fentanyl<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM179172.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Embeda</span></strong> (PDF - 39KB)</a>, capsules (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate; Naltrexone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM204267.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Exalgo</span></strong> (PDF - 83KB)</a>, tablets (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Hydromorphone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM088597.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Fentora</span></strong> (PDF - 338KB)</a>, tablets (buccal)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Fentanyl Citrate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311373.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Kadian</span></strong> (PDF - 135KB)</a>, capsules (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Methadone Hydrochloride</span></strong>, oral solution *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Methadone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Methadose</span></strong>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Methadone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Morphine Sulfate</span></strong>, tablets (immediate release) *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM199333.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Morphine Sulfate</span></strong> (PDF - 282KB)</a>, oral solution *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311374.pdf"><strong><span style="font-family:"Calibri","sans-serif"">MS Contin</span></strong> (PDF - 433KB)</a>, tablets (extended release) *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Morphine Sulfate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM270268.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Nucynta ER</span></strong> (PDF - 38KB)</a>, tablets (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Tapentadol<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM285397.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Onsolis
</span></strong>(PDF - 297KB)</a>, soluble film (buccal)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Fentanyl Citrate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Opana</span></strong>, tablets (immediate release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxymorphone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM283820.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Opana ER</span></strong> (PDF - 56KB)</a>, tablets (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxymorphone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Oxecta</span></strong>, tablets (immediate release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Oxycodone Hydrochloride</span></strong>, capsules<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM289880.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Oxycodone Hydrochloride</span></strong> (PDF - 100KB)</a>, oral solution<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM208530.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Oxycontin</span></strong> (PDF - 417KB)</a>, tablets (extended release)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Percocet</span></strong>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Acetaminophen; Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif"">Percodan</span></strong>, tablets *<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Aspirin; Oxycodone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><strong><span style="font-family:"Calibri","sans-serif""><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM225677.pdf">Suboxone</a></span></strong><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM225677.pdf"> (PDF - 83KB</a><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM225677.pdf">)</a>, film
(sublingual)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Buprenorphine Hydrochloride; Naloxone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM089830.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Xyrem</span></strong> (PDF - 185KB)</a>, oral solution<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Sodium Oxybate<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><a href="http://www.fda.gov/downloads/Drugs/DrugSafety/UCM362203.pdf"><strong><span style="font-family:"Calibri","sans-serif"">Zubsolv
</span></strong>(PDF - 354KB)</a>, tablets (sublingual)<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
<td style="padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal">Buprenorphine Hydrochloride; Naloxone Hydrochloride<span style="font-size:12.0pt"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>